Prosecution Insights
Last updated: July 14, 2026
Application No. 17/992,470

METHODS FOR THE PREVENTION OR TREATMENT OF ANTHRAX INFECTION

Final Rejection
Filed
Nov 22, 2022
Priority
Nov 24, 2021 — provisional 63/283,068
Examiner
LIU, SUE XU
Art Unit
1616
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Cumberland Pharmaceuticals Inc.
OA Round
2 (Final)
20%
Grant Probability
At Risk
3-4
OA Rounds
9m
Est. Remaining
37%
With Interview

Examiner Intelligence

Grants only 20% of cases
20%
Career Allowance Rate
47 granted / 234 resolved
-39.9% vs TC avg
Strong +16% interview lift
Without
With
+16.5%
Interview Lift
resolved cases with interview
Typical timeline
4y 5m
Avg Prosecution
19 currently pending
Career history
263
Total Applications
across all art units

Statute-Specific Performance

§101
1.8%
-38.2% vs TC avg
§103
64.1%
+24.1% vs TC avg
§102
4.3%
-35.7% vs TC avg
§112
9.3%
-30.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 234 resolved cases

Prosecution Timeline

Nov 22, 2022
Application Filed
May 07, 2025
Non-Final Rejection mailed
Aug 07, 2025
Response Filed
Sep 09, 2025
Final Rejection mailed
Apr 21, 2026
Response after Non-Final Action

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12616677
INJECTABLE PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
4y 6m to grant Granted May 05, 2026
Patent 12616206
GRAPHENE-SILVER NANOCOMPOSITES AND USES FOR SAME AS AN ANTIMICROBIAL COMPOSITION
3y 1m to grant Granted May 05, 2026
Patent 12616198
LIPO-CHITOOLIGOSACCHARIDE COMPOSITIONS FOR ENHANCING PLANT GROWTH
2y 0m to grant Granted May 05, 2026
Patent 12610946
FORMULATIONS FOR DECONTAMINATING A SURFACE
4y 8m to grant Granted Apr 28, 2026
Patent 12611374
DERMATOLOGICAL COLLAR FOR NON-HUMAN ANIMALS
4y 1m to grant Granted Apr 28, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
20%
Grant Probability
37%
With Interview (+16.5%)
4y 5m (~9m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 234 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month